Review of translation and development pathways and opportunities for cancer researchers
The University of Sydney Cancer Research Network has commissioned Bio-Link to undertake a review of translation and development pathways and opportunities for cancer researchers at the University of Sydney, its teaching hospitals and affiliated institutes.
Three stages of work will be undertaken:
- Stage 1 will explore the pathways for the translation of cancer research into clinical and commercial outcomes, focusing on therapeutics and biomarkers;
- Stage 2 will involve an audit of the development capabilities of University of Sydney cancer research; and
- Stage 3 will involve an assessment of whether there are opportunities for University of Sydney cancer researchers to provide services to external groups seeking to translate their own cancer discoveries.
The Drug Development Review, Cancer Biomarker Review and Service Provider Directory are now available to all members of the Cancer Research Network on the "For members” website.
Please note: These reports are for the information of University of Sydney Cancer Research Network members and are not intended for circulation to any other person, organisation or company.